Industry News
Australian Alzheimer's study launched
An Australian study to better understand the devastating and deadly Alzheimer's disease has been launched in Melbourne.
[ + ]Exciting times in the era of the electronic medical record
The mission and goals of hospital laboratories are changing rapidly with greater emphasis on activities such as point-of-care testing and outreach testing, working in tandem with other automated systems in the hospital.
[ + ]Embryonic stem cells and cancer formation
A Sydney research team has shown that encapsulating embryonic stem cells prevents the formation of tumours. [ + ]
DNA and protein identification in the same device?
A prototype device that could enable both DNA and protein identification and measurement in a single sample at the same time has received the backing of US giant Applied Biosystems. [ + ]
The body, the brain and Huntington's disease
Scientists at Melbourne's Howard Florey Institute have shown that physical exercise alone can delay onset of memory loss in Huntington's disease (HD), but a combination of mental and physical exercise is more beneficial in delaying the fatal genetic disease's symptoms. [ + ]
From laboratory to bedside
"It is not that stem cell transplantation doesn't work, it is just that we need more work to figure it out." With this kind of simple optimism, and a little green jasmine tea, Professor Brent Reynolds chatted with Fiona Wylie about life, coincidence and the use of neural stem cells to treat spinal cord injury. [ + ]
Spinal cord repair - just add water
The Australian Stem Cell Centre is studying an alternative approach to treating spinal cord damage using acellular dermal matrix processing. Fiona Wylie spoke to the ASCC's Kathy Traienedes. [ + ]
RNAi: sense and antisense
Gene silencing by small interfering RNAs (siRNAs) has emerged as an extremely useful technology for discovery biology, but off-target activity has proved a stumbling block. Detailed mechanistic insights and chemical modification of siRNAs can now improve the robustness of RNAi experiments, as Kate McDonald reports. [ + ]
GOBsmacking tales from the RNA world
Graeme O'Neill speaks with RNAi pioneer Peter Waterhouse and meets Drosha, Dicer, Argonaute and other characters. [ + ]
How green is our valley
Australia's much maligned native grasses have come in for a make-over in recent years. And as Graeme O'Neill reports, they needn't weep anymore. [ + ]
Peter Mac joins Affymetrix translational medicine program
Melbourne's Peter MacCallum Cancer Centre has entered into a five-year collaboration with Affymetrix to use the company's GeneChip microarray technology for translational research projects. Kate McDonald reports. [ + ]
Pathology Update 2007
When: 2-4 March 2007
Where: Sydney Convention Exhibition Centre
Registration: www.rcpa.edu.au/pathologyupdate
Prometheus unbound: caveolin and liver regeneration
It could be a long way off before we can take a 'caveolin pill' to fix our livers after a big night out, but a recent breakthrough by collaborating scientists in Brisbane and Barcelona has brought the possibility a little closer, as Fiona Wylie reports. [ + ]
Stem cells: how did your senators vote?
The bill to overturn the ban on using therapeutic cloning was passed by the Senate last night. We provide a breakdown of who voted and how. [ + ]
$12.5m partnership targets healthy grain
CSIRO, through the Food Futures Flagship, Limagrain Céréales Ingrédients and the Grains Research and Development Corporation (GRDC) have announced a partnership to accelerate the development of super-healthy wheat varieties.
[ + ]